Hydromorphone: A cost-effective alternative to the use of oxymorphone

Canadian Veterinary Journal

Volumn 41, Issue 2, 2000, Pages 135-137

  Pettifer, Glenn ^a,b   Dyson, Doris ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEPROMAZINE; DROPERIDOL; FENTANYL CITRATE; HYDROMORPHONE; OXYMORPHONE; TRANQUILIZER;

ANIMAL EXPERIMENT; CLINICAL PRACTICE; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DRUG CONTRAINDICATION; DRUG COST; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENCY; HISTAMINE RELEASE; HUMAN; LICENSING; NONHUMAN; PAIN; PREMEDICATION; RESPIRATION DEPRESSION; SEDATION; SHORT SURVEY; URINE RETENTION; VOLVULUS;

ANALGESICS, OPIOID; ANIMALS; CAT DISEASES; CATS; COST-BENEFIT ANALYSIS; DOG DISEASES; DOGS; HYDROMORPHONE; OXYMORPHONE; VETERINARY MEDICINE;

ANIMALIA;

EID: 0034011521     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (5)

1. Torske KE, Dyson DH, Conlon PD. Cardiovascular effects of epidurally administered oxymorphone and an oxymorphone-bupivacaine combination in halothane-anesthetized dogs. Am J Vet Res 1999;60:194-200.
2. Ilkiw JE, Pascoe PJ, Haskins SC, Patz JD, Jaffe R. The cardiovascular sparing effect of fentanyl and atropine, administered to enflurane anesthetized dogs. Can J Vet Res 1994;58:248-253.
3. Haskins SC, Copland VS, Patz JD. The cardiopulmonary effects of oxymorphone in hypovolemic dogs. Vet Emerg Crit Care 1991;1(2):32-38.
4. Ennis M, Schneider C, Nehring E, Lorenz W. Histamine release induced by opioid analgesics: a comparative study using porcine mast cells. Agents Actions 1991;33(1-2):20-22.
5. Brose WG, Tanelian DL, Brodsky JB, Mark JB, Cousins MJ. CSF and blood pharmacokinetics of hydromorphone and morphine following lumbar epidural administration. Pain 1991;45:11-15.